Outgoing Novartis CEO Hunts for His Next Big Challenge Post author:Sam Post published:January 24, 2018 Post category:BioPharma Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis. Source: BioSpace You Might Also Like Onxeo Reports First-Half 2017 Results And Business Update July 30, 2017 Clinigen And Cumberland Pharmaceuticals Launch Totect In The U.S. For Emergency Oncology Intervention September 24, 2017 Alzheon To Present Novel Molecular Mechanism Of Action And Long Term Clinical Efficacy Data For Lead Candidate ALZ-801 At June 21, 2017
Clinigen And Cumberland Pharmaceuticals Launch Totect In The U.S. For Emergency Oncology Intervention September 24, 2017
Alzheon To Present Novel Molecular Mechanism Of Action And Long Term Clinical Efficacy Data For Lead Candidate ALZ-801 At June 21, 2017